Telomere length variation and maintenance in hepatocarcinogenesis. (Q54766150)

3 June 2018

title

Telomere length variation and maintenance in hepatocarcinogenesis. (English)

1 reference

3 June 2018

0 references

6

Hirokazu Kawai

1 reference

3 June 2018

Yusaku Mita

7

object named as

Yusaku Mita

1 reference

3 June 2018

author name string

Takashi Yokota

1

1 reference

3 June 2018

Takeshi Suda

2

1 reference

3 June 2018

Masato Igarashi

3

1 reference

3 June 2018

Takashi Kuroiwa

4

1 reference

3 June 2018

Nobuo Waguri

5

1 reference

3 June 2018

Yutaka Aoyagi

8

1 reference

3 June 2018

language of work or name

English

0 references

publication date

1 July 2003

1 reference

3 June 2018

published in

Cancer

1 reference

3 June 2018

volume

98

1 reference

3 June 2018

issue

1

1 reference

3 June 2018

page(s)

110-118

1 reference

3 June 2018

Telomerase activity and metastasis: expansion of cells having higher telomerase activity within culture lines and tumor tissues.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11428

Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11428

Telomeres shorten during ageing of human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11428

7 January 2021

Specific association of human telomerase activity with immortal cells and cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11428

7 January 2021

Telomere length regulation during postnatal development and ageing in Mus spretus

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11428

7 January 2021

Telomeres in the mouse have large inter-chromosomal variations in the number of T2AG3 repeats

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11428

7 January 2021

Heterogeneity in telomere length of human chromosomes.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11428

7 January 2021

Loss of a yeast telomere: arrest, recovery, and chromosome loss.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11428

7 January 2021

Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11428

7 January 2021

Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11428

7 January 2021

Position effect at S. cerevisiae telomeres: reversible repression of Pol II transcription

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11428

7 January 2021

MEC1-dependent redistribution of the Sir3 silencing protein from telomeres to DNA double-strand breaks

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11428

7 January 2021

The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11428

7 January 2021

Control of telomere length by the human telomeric protein TRF1

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11428

7 January 2021

TRF2 Protects Human Telomeres from End-to-End Fusions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11428

7 January 2021

Tankyrase, a poly(ADP-ribose) polymerase at human telomeres

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11428

7 January 2021

hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11428

7 January 2021

Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11428

7 January 2021

Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11428

7 January 2021

Hepatocellular carcinoma: Recent progress

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11428

7 January 2021

Reduction of telomeric repeats as a possible predictor for development of hepatocellular carcinoma: convenient evaluation by slot-blot analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11428

7 January 2021

The Shortest Telomere, Not Average Telomere Length, Is Critical for Cell Viability and Chromosome Stability

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11428

7 January 2021

Effects of reconstitution of telomerase activity on telomere maintenance by the alternative lengthening of telomeres (ALT) pathway

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11428

7 January 2021

Interchromosomal telomere length variation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11428

7 January 2021

Telomere reduction in human colorectal carcinoma and with ageing

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11428

7 January 2021

Intrachromosomal location of the telomeric repeat (TTAGGG)n.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11428

7 January 2021

Extra-chromosomal telomere repeat DNA in telomerase-negative immortalized cell lines

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11428

7 January 2021

Expression of telomerase-associated protein 1 and telomerase reverse transcriptase in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11428

7 January 2021

Correlating telomerase activity levels with human neuroblastoma outcomes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11428

7 January 2021

Quantitation of telomerase activity in hepatocellular carcinoma: a possible aid for a prediction of recurrent diseases in the remnant liver

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11428

7 January 2021

Design of telomerase inhibitors for the treatment of cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11428

7 January 2021

Telomestatin, a potent telomerase inhibitor that interacts quite specifically with the human telomeric intramolecular g-quadruplex

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11428

7 January 2021

Identifiers

DOI

10.1002/CNCR.11428

1 reference

3 June 2018

PubMed ID

12833463

1 reference

3 June 2018